S-1: Actelis Networks Launches $5M Public Offering

Sentiment:

Public Offering Registration Statement 12 December 2025 4:45 PM

Actelis Networks, Inc. announces a best-efforts public offering of common stock and warrants to raise up to $5 million for general corporate purposes, alongside details of recent financing activities and ongoing Nasdaq compliance.

Capital raiseCurrent Public Offering: Up to 1,639,344 shares of common stock and 1,639,344 common warrants, with an assumed combined public offering price of $3.05 per share/warrant, aiming for approximately $4.46 million in net proceeds.July 2025 Private Placement: Issued 162,602 shares, Series A-3 warrants, and Series A-4 warrants for approximately $1 million gross proceeds.September 2025 Warrant Inducement: Generated approximately $1.6 million gross proceeds from the exercise of existing warrants at a reduced price, in exchange for new warrants.Equity Line of Credit (ELOC) Agreement (Sept 27, 2025): Provides the right to require White Lion Capital, LLC to purchase up to $30,000,000 of newly issued common stock.PIPE Purchase Agreement (Sept 27, 2025): Issued 87,177 shares and pre-funded warrants for approximately $850,000 gross proceeds to White Lion.

Summary

Actelis Networks is offering up to 1,639,344 shares of common stock and 1,639,344 common warrants in a best-efforts public offering.
Pre-funded warrants are also offered to purchasers whose acquisition of common stock would exceed beneficial ownership limits.
The assumed combined public offering price is $3.05 per share of common stock and accompanying common warrant, based on the closing price on December 9, 2025.
The estimated net proceeds from the offering are approximately $4.46 million, assuming the maximum number of common stock are sold and no pre-funded warrants are issued.
Proceeds are intended for general corporate purposes, including pipeline product development and new programs.
The company reported a net loss of $5.7 million for the nine months ended September 30, 2025, and $2.6 million for the nine months ended September 30, 2024.
Actelis Networks had an accumulated deficit of $50 million as of September 30, 2025.
A 10-for-1 reverse stock split was effected on November 18, 2025.
The company regained compliance with Nasdaq's Bid Price Rule and Shareholders Equity Requirement on December 3, 2025, but remains under a one-year Panel Monitor until December 5, 2026.
Recent financing activities include a July 2025 private placement that raised approximately $1 million, a September 2025 warrant inducement generating approximately $1.6 million, and an Equity Line of Credit Agreement with White Lion Capital, LLC for up to $30 million.
The company's core business focuses on cyber-hardened, rapid-deployment networking solutions for wide-area IoT applications, utilizing hybrid fiber and existing copper/coaxial lines.

Sentiment

Score: 4

Explanation: The company is actively addressing its capital needs and has successfully regained Nasdaq compliance, which are positive steps. However, a history of significant losses, accumulated deficit, and the 'best-efforts' nature of the offering, coupled with potential dilution, indicate ongoing financial challenges and risks.

Positives

Regained compliance with Nasdaq's Bid Price Rule and Shareholders Equity Requirement, resolving previous delisting concerns.
Successfully completed recent capital raises, including a July 2025 private placement ($1 million gross proceeds) and a September 2025 warrant inducement ($1.6 million gross proceeds).
Secured an Equity Line of Credit Agreement for up to $30 million with White Lion Capital, LLC, providing a potential source of future capital.
Company's hybrid fiber networking solutions address critical needs in wide-area IoT, federal, DoD, and multi-dwelling unit markets, offering cost-effective and secure connectivity.

Negatives

The company has a history of significant net losses, reporting $5.7 million for the nine months ended September 30, 2025, and $2.6 million for the nine months ended September 30, 2024.
An accumulated deficit of $50 million as of September 30, 2025, indicates ongoing financial challenges.
The current offering is on a 'best-efforts' basis, meaning there is no guarantee that all securities will be sold or that the target amount of capital will be raised.
New investors will experience immediate dilution in the book value per share, as the offering price is substantially higher than the net tangible book value per share prior to the offering.
Common Warrants may require stockholder approval to be exercisable, which is not guaranteed and could delay their value realization.
There is no established public trading market for the common warrants and pre-funded warrants, limiting their liquidity.
The company remains subject to a one-year Nasdaq Panel Monitor until December 5, 2026, indicating continued scrutiny over listing compliance.

Risks

History of net losses and the inability to achieve or sustain profitability in the future.
Need for additional capital to fund operations and growth, with no assurance that such capital will be available on acceptable terms or at all.
Potential for delisting from the Nasdaq Capital Market if the company fails to maintain compliance with listing standards, despite recent regain of compliance.
Operations in Israel are subject to political instability and armed conflicts in the Middle East, which could materially and adversely affect business, financial condition, and operating results.
The 'best efforts' structure of this offering may result in insufficient capital being raised to implement the company's business plan, potentially leading to greater operating losses.
Significant dilution in the book value per share for investors purchasing common stock in this offering, and further dilution from the exercise of outstanding warrants and options.
The price of common stock may be volatile and decline due to various factors beyond the company's control.
Common Warrants may have no value if stockholder approval for their exercise is not obtained or if the market price of the common stock does not exceed the exercise price.
No public market exists for the common warrants or pre-funded warrants, limiting their liquidity.
Potential insufficiency of disclosure controls and procedures to detect errors or acts of fraud.
Challenges in protecting intellectual property and continuing to innovate.
Difficulties in retaining or recruiting officers, key employees, or directors.
Competition from existing or new products or technologies.
Uncertainty resulting from pandemics (e.g., COVID-19) affecting business growth.
Inability to comply with complex and increasing governmental regulations.
Economic boycotts against Israel and Israeli companies could adversely affect business.
Commercial insurance does not cover losses from events associated with the security situation in the Middle East.

Future Outlook

The company intends to use the net proceeds from this offering for continued development of its pipeline products, advancement of new programs, business development activities, and general corporate purposes. With the maximum estimated net proceeds of $4.46 million from this offering, combined with existing cash and cash equivalents, the company believes it can meet its capital needs through the end of the second quarter of 2027. However, if lower proceeds are realized, this period shortens significantly, for example, to the end of the second quarter of 2026 with $2.62 million in net proceeds. The company also has access to an Equity Line of Credit for up to $30 million, providing a potential source of additional capital.

Management Comments

Our unique portfolio of hybrid fiber, environmentally hardened aggregation switches, high density Ethernet devices, advanced management software and cyber-protection capabilities, unlocks the hidden value of essential networks, delivering safer connectivity for rapid, cost-effective deployment.
We believe that our solutions can provide connectivity over either fiber or copper with speeds of up to multi-Gigabit communication, while supporting Fiber-grade reliability and quality.
We believe that combining communication and power over the same existing lines is particularly important to help connect many fifth generation, or 5G, small cells and Wi-Fi base stations, as high cost of connectivity and power is often slowing their deployment.

Industry Context

Actelis Networks operates in the growing wide-area IoT, federal, DoD, and multi-dwelling unit markets, providing specialized cyber-hardened networking solutions. Its patented hybrid fiber-copper technology offers a distinct advantage by upgrading existing copper and coaxial lines to fiber-grade performance, significantly reducing the cost and time associated with deploying new fiber infrastructure to hard-to-reach locations. This approach is particularly relevant for accelerating the deployment of modern IoT networks and 5G small cells, where high connectivity and power costs are significant barriers. The company's focus on secure, high-speed, and cost-effective solutions positions it to capitalize on the increasing demand for robust network infrastructure in these critical sectors.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Vacancy Filling	Vacancies on the board of directors may be filled only by the affirmative vote of a majority of the directors then in office, irrespective of whether there is a quorum, or by a sole remaining director.	NA	Prevents stockholders from unilaterally increasing board size and filling vacancies, promoting management continuity.
Board Structure	The board of directors is divided into three classes with staggered three-year terms, with only one class elected at each annual meeting.	NA	May delay or prevent a change of management or a change in control by making it more difficult to replace a majority of directors.
Special Meetings of Stockholders	Special meetings of stockholders may only be called by the board of directors (majority vote), the Chief Executive Officer or President, or by holders of not less than 25% of the voting stock.	NA	Restricts the ability of a minority of shareholders to call special meetings, potentially limiting shareholder activism.
Voting Rights	The Charter does not provide for cumulative voting in the election of directors.	NA	Limits the ability of minority shareholders to elect directors, reinforcing the power of majority shareholders.
Charter Amendments	Any amendment to the Charter requires the affirmative vote of a majority of outstanding shares, with the staggered board provision requiring not less than 80% of voting stock.	NA	Makes it difficult to amend key corporate governance provisions, particularly those related to board structure.
Bylaw Amendments	Amendments to the Bylaws may be executed by a majority vote of the Board of Directors or by the affirmative vote of at least 75% of the outstanding shares of capital stock entitled to vote.	NA	Requires a supermajority shareholder vote or board approval for bylaw changes, providing stability but potentially limiting flexibility.
Delaware Business Combination Statute	The company is subject to Section 203 of the DGCL, which prohibits business combinations with interested stockholders for three years unless approved in a prescribed manner.	NA	Has an anti-takeover effect, discouraging attempts to acquire control not approved by the Board of Directors.
Exclusive Forum Provision	The Court of Chancery of the State of Delaware is the sole and exclusive forum for certain corporate actions, and federal district courts for Exchange Act/Securities Act claims.	NA	May limit a stockholder's ability to bring claims in a preferred judicial forum, potentially discouraging lawsuits against the company or its directors/officers.
Director Liability	The Charter and Bylaws limit the liability of directors for monetary damages to the fullest extent permitted by the DGCL, with specific exceptions.	NA	Protects directors from personal monetary liability for certain breaches of fiduciary duty, potentially encouraging board service but limiting recourse for shareholders.

Stakeholder Impact

Shareholders: Potential for significant dilution from the offering and future warrant exercises. The capital raise aims to support business growth, but continued losses pose risks to investment value.
Employees: Continued investment in research and development and business expansion could provide job stability and growth opportunities. However, operations in Israel face risks from regional conflicts.
Customers: Enhanced product development and business expansion, funded by the capital raise, could lead to improved solutions and service offerings.
Creditors: The capital raise could improve the company's financial stability and liquidity, potentially reducing credit risk.

Next Steps

Complete the current best-efforts public offering by December 31, 2025.
Seek Warrant Stockholder Approval for the issuance of shares upon exercise of common warrants, if Pricing Conditions are not met, by holding annual or special meetings.
Continue to develop pipeline products and advance new programs.
Engage in business development activities.
Maintain Nasdaq listing compliance, remaining subject to a one-year Panel Monitor until December 5, 2026.
File a registration statement with the SEC to register common stock for resale by White Lion under the ELOC.
Call special shareholder meetings to obtain approval for ELOC share issuance beyond the Exchange Cap, if not obtained at the first meeting, every 90 days for 360 days.

Key Dates

Date	Description
2023-08-25	Received Nasdaq notification of non-compliance with Minimum Shareholders Equity Requirement.
2023-12-20	Closed a private placement of 30,100 shares, 97,019 pre-funded warrants, and 127,119 common warrants for $1.5 million gross proceeds.
2024-03-27	Received Nasdaq delist determination letter due to Minimum Shareholders Equity non-compliance.
2024-06-06	Closed warrant inducement transaction, generating $3.0 million gross proceeds.
2024-07-02	Closed warrant inducement transaction, generating $2.25 million gross proceeds.
2024-08-27	Received formal notice from Nasdaq confirming compliance with all applicable criteria for continued listing, including Minimum Shareholders Equity Requirement.
2025-05-12	Received Nasdaq notification of non-compliance with Bid Price Rule ($1.00 minimum).
2025-06-30	Entered into a securities purchase agreement for July 2025 Private Placement.
2025-07-02	Closed July 2025 Private Placement, raising approximately $1 million gross proceeds.
2025-08-19	Received Nasdaq notice of non-compliance with Minimum Shareholders Equity Requirement as of June 30, 2025, triggering a mandatory hearing.
2025-09-02	Entered into inducement agreement for warrant exercise, generating $1.6 million gross proceeds.
2025-09-03	Closed warrant inducement transaction.
2025-09-27	Entered into Common Stock Purchase Agreement (Equity Line of Credit) with White Lion Capital, LLC for up to $30 million.
2025-09-27	Entered into PIPE Purchase Agreement with White Lion, raising approximately $850,000 gross proceeds.
2025-09-29	Closed PIPE Purchase Agreement.
2025-09-30	Hearing with Nasdaq Panel regarding Minimum Shareholders Equity Requirement.
2025-10-01	Effective date of Common Stock Purchase Agreement with White Lion.
2025-10-09	Amendment to Inducement Letter, issuing 10,000 warrants.
2025-10-20	Reduced number of shares issuable from Pre-Funded Warrants by 48,826.
2025-10-28	Received Nasdaq listing decision confirming compliance with Shareholders Equity Requirement and granting exception until December 5, 2025, to regain bid price compliance.
2025-11-07	Shareholders approved Reverse Split and Warrant Stockholder Approval.
2025-11-10	Deadline to regain compliance with Nasdaq Bid Price Rule.
2025-11-18	10-for-1 Reverse Share Split effected.
2025-12-03	Received formal notice from Nasdaq of regaining compliance with Bid Price Rule and other listing criteria.
2025-12-05	End of exception period for Nasdaq bid price compliance.
2025-12-09	Closing price of common stock on Nasdaq was $2.66 per share.
2025-12-11	Closing price of common stock on Nasdaq was $2.66 per share.
2025-12-12	Filing date of the S-1 Registration Statement.
2025-12-31	Offering termination date.
2026-06-30	Estimated capital needs met through this date if $2.62 million net proceeds from offering are received.
2026-12-05	End of one-year Nasdaq Panel Monitor period.
2026-12-31	Estimated capital needs met through this date if $3.54 million net proceeds from offering are received.
2027-06-30	Estimated capital needs met through this date if $4.46 million net proceeds from offering are received.
2028-10-01	End of Commitment Period for Equity Line of Credit with White Lion.

Recommendation

hold

Actelis Networks is actively addressing its capital needs and has successfully regained Nasdaq compliance, which are positive indicators of management's efforts. The company's focus on cyber-hardened hybrid networking solutions for critical IoT infrastructure presents a compelling market opportunity. However, the significant history of net losses and accumulated deficit, coupled with the dilutive nature of the current 'best-efforts' offering and the inherent risks associated with operations in Israel, suggest a cautious approach. While the Equity Line of Credit provides a potential funding backstop, the company's ability to achieve sustained profitability remains unproven. Investors should hold to monitor the effective deployment of the raised capital, progress towards profitability, and the impact of geopolitical risks.

Keywords

Actelis Networks, ASNS, Public Offering, Common Stock, Warrants, Pre-Funded Warrants, Capital Raise, Nasdaq Compliance, IoT Solutions, Hybrid Fiber, Cyber-hardened Networking, Financial Reporting, Risk Factors, Dilution, Equity Line of Credit, Israel Operations, Best Efforts Offering, SEC S-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.